The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Acoustic Neuroma (Vestibular Schwannoma)

Benign Schwann cell tumor arising from vestibular division of cranial nerve VIII at the cerebellopontine angle, causing progressive unilateral sensorineural hearing loss, tinnitus, and disequilibrium, with management options including observation, stereotactic radiosurgery, or microsurgical resection based on tumor size, growth rate, hearing status, and patient factors.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our KBB (Kulak Burun Boğaz) department. Book Appointment →

What is Acoustic Neuroma (Vestibular Schwannoma)?

Acoustic neuroma, more accurately termed vestibular schwannoma (VS), is a benign tumor arising from Schwann cells of the vestibular branch of the eighth cranial nerve (vestibulocochlear nerve), most commonly originating at the junction between central and peripheral myelin (Obersteiner-Redlich zone) within the internal auditory canal (IAC). The tumor expands slowly (1-2 mm/year average), gradually filling the IAC and extending into the cerebellopontine angle (CPA), eventually compressing the cochlear nerve (hearing loss), facial nerve, trigeminal nerve, and brainstem.

Most cases (95%) are unilateral and sporadic, while bilateral acoustic neuromas pathognomonically suggest neurofibromatosis type 2 (NF2), a genetic disorder caused by mutations in the merlin/schwannomin gene on chromosome 22. Sporadic VS is more common in adults aged 30-60, with peak incidence in the fifth decade. Risk factors are largely unknown, with possible associations including childhood head/neck radiation and prolonged loud noise exposure.

Diagnosis is established with gadolinium-enhanced MRI of the IAC and CPA showing an enhancing mass, often described as having an 'ice cream cone' shape with intracanalicular and CPA components. Audiometry reveals asymmetric sensorineural hearing loss with poor word recognition. Auditory brainstem response (ABR) shows prolonged wave V latency and interaural latency difference. Vestibular testing (caloric, VEMP) often shows ipsilateral hypofunction. Tumor size classification: intracanalicular, small (<1.5 cm CPA), medium (1.5-3 cm), large (>3 cm).

Symptoms

Unilateral progressive sensorineural hearing loss (95%)
Unilateral tinnitus (high-pitched, ringing)
Sudden sensorineural hearing loss (10-20% present this way)
Imbalance, unsteadiness (vestibular dysfunction)
Facial numbness or pain (trigeminal involvement, large tumors)
Facial weakness (rare, late finding)
Headache, hydrocephalus symptoms (very large tumors)

Risk Factors

Neurofibromatosis type 2 (NF2) — bilateral schwannomas
Age 30-60 (sporadic)
Prior childhood radiation exposure
Prolonged loud noise exposure (debated)
Family history (rare in sporadic)
No clear environmental causal factors
More common in Caucasians

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Asymmetric or unilateral hearing loss (>10 dB difference)
  • Unilateral tinnitus persisting >6 months
  • Sudden sensorineural hearing loss (urgent ENT)
  • Unexplained imbalance with hearing changes
  • Facial numbness or weakness
  • Family history of NF2 (genetic counseling)
  • Audiometry showing asymmetric hearing loss

Treatment Methods

01
Watchful waiting with serial MRI (small tumors, elderly, slow growth)
02
Stereotactic radiosurgery (Gamma Knife, CyberKnife, LINAC) for tumors <3 cm
03
Microsurgical resection: translabyrinthine (large tumors, no hearing)
04
Retrosigmoid approach (hearing preservation possible)
05
Middle fossa approach (small intracanalicular tumors with hearing)
06
Hearing rehabilitation: hearing aids, BAHA, cochlear implant (NF2)
07
Postoperative facial nerve rehabilitation if needed

Which Department to Visit?

You can visit our KBB (Kulak Burun Boğaz) department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About KBB (Kulak Burun Boğaz) Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.